[The effect of molsidomine preparations on the coronary and myocardial reserves of patients with IHD complicated by circulatory failure].

Molsidomine drugs corvaton and sidnopharm were given as monotherapy to 95 coronary heart disease (CHD) patients with circulatory defects. Positive effects on coronary and myocardial reserves were reported in 70,8 and 58.3%, 68,4 and 56.8% of cases, respectively. Corvaton caused side effects in 3.1%, sidnopharm in 12.5% of the patients. Corvaton is more potent as regards hemodynamics, myocardial contractility and reserves.